Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)3.27
  • Today's Change0.07 / 2.19%
  • Shares traded89.39m
  • 1 Year change-32.85%
  • Beta1.9252
Data delayed at least 15 minutes, as of May 17 2024 09:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Alibaba Health Information Technology Ltd grew revenues 30.06% from 20.58bn to 26.76bn. In addition the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as a percent of sales). The company reported positive net income, improving from a loss of 265.56m to a profit of 533.41m.
Gross margin22.22%
Net profit margin2.90%
Operating margin3.05%
Return on assets3.91%
Return on equity5.28%
Return on investment5.21%
More ▼

Cash flow in CNYView more

In 2023, Alibaba Health Information Technology Ltd did not generate a significant amount of cash. However, the company earned 255.69m from its operations for a Cash Flow Margin of 0.96%. In addition the company used 532.44m on investing activities and also paid 111.28m in financing cash flows.
Cash flow per share0.0694
Price/Cash flow per share54.54
Book value per share1.29
Tangible book value per share1.20
More ▼

Balance sheet in CNYView more

Alibaba Health Information Technology Ltd has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 10.92bn.
Current ratio3.01
Quick ratio2.68
Total debt/total equity0.0055
Total debt/total capital0.0055
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.